undamentalytics Newsletter

Evans Daron: insider trades

Chief executive, Chief financial officer at 2 companies we cover. 20 open-market purchases and no sales not made under a pre-set plan, reported from August 20, 2015 to March 31, 2026.

Would copying Evans Daron’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 3 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on August 23, 2019 into $13,147 by November 2, 2026, +3.9% a year. The copy held shares only 22% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $17,465, +8.1% a year (the S&P 500 held throughout made $29,487, +16.3% a year). Beta against the index was 0.29. Twelve months after each report, the average purchase was −33.0% against the S&P 500 (median −38.1%), and 0% beat it. Measured from the trade date, the insider’s own timing, the average was −32.6%.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$10.0k$20.0k$30.0k 20192020202120222023202420252026 $29.5k$17.5k$13.1k
Copying Evans DaronS&P 500, same days investedS&P 500, held throughout $10,000 copying Evans Daron’s open-market purchases from August 23, 2019, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+3.9%
S&P 500, same days invested
+8.1% (held throughout +16.3%)
Time in shares
22%
Sharpe ratio (S&P 500)
0.18 (0.72)
Biggest drop (S&P 500)
−51% (−34%)
Market sensitivity (beta)
0.29
Purchases copied
3

Trade by trade

Evans Daron: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 3 −0.3% +3.7% 67% 2 — — Not enough years
Purchases, 6 months after the report 3 −13.6% −23.9% 33% 2 — — Not enough years
Purchases, 12 months after the report 3 −33.0% −38.1% 0% 2 — — Not enough years
Purchases, 12 months after the trade 3 −32.6% −37.7% 0% 2 — — Not enough years
Sales, 3 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the trade 0 — — — — — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Rezolute, Inc. RZLT CFO110February 20, 2024March 31, 2026
Nephros Inc NEPH President and CEO90August 20, 2015March 12, 2020

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
March 31, 2026March 30, 2026 RZLT Purchase $28,500 not yetnot yetnot yet
December 15, 2025December 15, 2025 RZLT Purchase $79,750 not yetnot yetnot yet
June 24, 2025June 24, 2025 RZLT Purchase $20,250 not yetnot yetnot yet
March 28, 2025March 26, 2025 RZLT Purchase $57,700 not yetnot yetnot yet
December 18, 2024December 18, 2024 RZLT Purchase $42,900 not yetnot yetnot yet
December 12, 2024December 12, 2024 RZLT Purchase $41,400 not yetnot yetnot yet
December 10, 2024December 9, 2025 RZLT Purchase $53,167 not yetnot yetnot yet
June 14, 2024June 14, 2024 RZLT Purchase $161,600 not yetnot yetnot yet
March 19, 2024March 15, 2024 RZLT Purchase $33,800 not yetnot yetnot yet
March 8, 2024March 8, 2024 RZLT Purchase $96,500 not yetnot yetnot yet
February 20, 2024February 16, 2024 RZLT Purchase $66,800 not yetnot yetnot yet
March 12, 2020March 12, 2020 NEPH Purchase $16,625 +3.7%−41.4%−46.1%
March 5, 2020March 5, 2020 NEPH Purchase $21,100 −13.4%−38.1%−37.7%
August 22, 2019August 22, 2019 NEPH Purchase $13,840 +8.8%−19.6%−13.9%
June 14, 2019June 14, 2019 NEPH Purchase $25,743 not yetnot yetnot yet
April 12, 2018April 10, 2018 NEPH Purchase $35,550 not yetnot yetnot yet
August 11, 2017August 11, 2017 NEPH Purchase $18,200 not yetnot yetnot yet
December 2, 2016November 30, 2016 NEPH Purchase $13,262 not yetnot yetnot yet
August 31, 2015August 27, 2015 NEPH Purchase $25,338 not yetnot yetnot yet
August 20, 2015August 19, 2015 NEPH Purchase $27,370 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Evans Daron traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.